Marketing Psychiatric Drugs to Jailers and Judges

Medications Make Mad Money –

Dec. 31, 2019 – At recent conferences about correctional health care, Merck, Gilead, AbbVie, and other big pharmaceutical companies have staged “product theaters” or “education luncheons” that show how their products could help treat inmates. The criminal-justice system isn’t just a lucrative market because of current inmates; it also introduces incarcerated people to medication that they might continue using after they’re released. (The full cash price of Aristada is about $1,300 for a four-week shot. The drug is covered by Medicaid and Medicare but can still require hefty copays.) 

Full Story @TheAtlantic

Leonard Buschel

Share
Published by
Leonard Buschel

Recent Posts

Pain Medication for Dogs Linked to Illnesses and Death

WHO DO YOU SUE? – Dec. 18, 2024 -  The U.S. Food and Drug Administration…

1 day ago

John Coltrane Quartet – My Favorite Things LIVE

VIDEO – MUSICAL INTERLUDE – 1965 - 786,695 views Since Aug 4, 2022 - Soprano Saxophone…

1 day ago

A Charlie Brown Christmas – Opening

VIDEO – MERRY CHRISTMAS EVE – 1965 - 1,465,813 views since   Jan 20, 2010…

1 day ago

How RFK Jr.’s History With Heroin Matters

AUDIO – WELLNESS FARMS COMING? – Dec. 17, 2024 - Robert F. Kennedy, Jr., President-elect…

1 day ago

‘Christmas was dad’s excuse to start drinking early’

‘TIS THE SEASON... – Dec, 18, 2024 - “There’s already an excuse to start drinking…

1 day ago

PBS News Weekly: Rethinking Addiction

VIDEO ONLY – METHADONE FOR ALL MY FRIENDS – Dec. 20, 2024 - Millions of…

1 day ago